Glipizide Dosing Considerations in Renal Impairment

Introduction to Glipizide Dosing

The American Diabetes Association recommends glipizide dosing adjustments based on eGFR, with no dose adjustment required for eGFR >50 mL/min/1.73 m² 1
For patients with eGFR <50 mL/min/1.73 m², the American College of Clinical Endocrinologists suggests starting with a conservative initial dose of 2.5 mg daily and using caution with long-acting formulations due to hypoglycemia risk 1

In patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), the National Kidney Foundation recommends glipizide as an option since it is primarily hepatically metabolized, with initiation at 2.5 mg daily and careful monitoring 1
The European Association for the Study of Diabetes advises avoiding glyburide entirely in patients with severe renal impairment as it is contraindicated 1

For patients with eGFR <30 mL/min/1.73 m², the American Diabetes Association suggests considering DPP-4 inhibitors, which may be preferable, though require dose adjustment (except linagliptin) 1
The European Renal Association recommends GLP-1 receptor agonists like liraglutide, dulaglutide, or semaglutide, which require no dose adjustment and have lower hypoglycemia risk 1, 2
The International Society of Nephrology notes that insulin remains effective regardless of renal function with dose adjustment based on clinical response 2

The American College of Clinical Endocrinologists advises that glyburide is contraindicated in renal impairment due to renal excretion and accumulation risk 1
The National Kidney Foundation recommends discontinuing metformin if eGFR <30 mL/min/1.73 m² 1, 2

The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend SGLT2 inhibitors for patients with type 2 diabetes and eGFR ≥30 mL/min/1.73 m² due to cardiovascular and kidney benefits, with a Grade 1A recommendation 3
When adding an SGLT2 inhibitor to meet cardiovascular or kidney protection goals, consider reducing or discontinuing the sulfonylurea to prevent hypoglycemia, as per the KDIGO 2020 guidelines 3